NIH #T32CA071345
Training Program in Cancer Biology and Therapeutics
Active
- Amount
- $600K–$700K
- Period
- 1997-08-01 → 2028-06-30
- PIs
- 2
Awarded at MASSACHUSETTS GENERAL HOSPITAL
Lecia V. Sequist
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index119
i10-index331
Publications817
Citations77,535
Grants
5 total · 4 active
NIH #P50CA265826
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
Active
- Amount
- $2M–$3M
- Period
- 2022-08-01 → 2027-07-31
- PIs
- 2
Awarded at DANA-FARBER CANCER INST
NIH #R01CA137008
Non-genomic resistance mechanisms in EGFR-mutant lung cancer
Active
- Amount
- $400K–$500K
- Period
- 2009-03-01 → 2027-05-31
- PIs
- 2
Awarded at MASSACHUSETTS GENERAL HOSPITAL
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New preprint: Pillar-0: A New Frontier for Radiology Foundation Models2025-12-17
- New paper: Supplementary Methods, Tables, Figures from Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, <i>MET</i>-Amplified Non–Small Cell Lung Cancer: TATTON2025-12-10
- New NIH award: A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications2024-02-12
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-30
Data may not be current
Find elsewhere
ORCID: 0000-0002-8965-6991